245 related articles for article (PubMed ID: 37762467)
21. Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies.
Zhang Y; Chen J; Qiu J; Li Y; Wang J; Jiao J
Am J Clin Nutr; 2016 Feb; 103(2):330-40. PubMed ID: 26718417
[TBL] [Abstract][Full Text] [Related]
22. Polyunsaturated fatty acids and risk of Alzheimer's disease: a Mendelian randomization study.
Tomata Y; Larsson SC; Hägg S
Eur J Nutr; 2020 Jun; 59(4):1763-1766. PubMed ID: 31676950
[TBL] [Abstract][Full Text] [Related]
23. The contribution of vascular risk factors in neurodegenerative disorders: from mild cognitive impairment to Alzheimer's disease.
Cheng YW; Chiu MJ; Chen YF; Cheng TW; Lai YM; Chen TF
Alzheimers Res Ther; 2020 Aug; 12(1):91. PubMed ID: 32753051
[TBL] [Abstract][Full Text] [Related]
24. Visualizing Hyperactivation in Neurodegeneration Based on Prefrontal Oxygenation: A Comparative Study of Mild Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls.
Yap KH; Ung WC; Ebenezer EGM; Nordin N; Chin PS; Sugathan S; Chan SC; Yip HL; Kiguchi M; Tang TB
Front Aging Neurosci; 2017; 9():287. PubMed ID: 28919856
[No Abstract] [Full Text] [Related]
25. Olfactory memory in mild cognitive impairment and Alzheimer's disease.
Audronyte E; Sutnikiene V; Pakulaite-Kazliene G; Kaubrys G
Front Neurol; 2023; 14():1165594. PubMed ID: 37332995
[TBL] [Abstract][Full Text] [Related]
26. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
[TBL] [Abstract][Full Text] [Related]
27. Verification of the association between cognitive decline and olfactory dysfunction using a DEmentia screening kit in subjects with Alzheimer's dementia, mild cognitive impairment, and normal cognitive function (DESK study): A multicenter, open-label, interventional study.
Fukumoto T; Ezaki T; Urakami K
eNeurologicalSci; 2022 Dec; 29():100439. PubMed ID: 36531966
[TBL] [Abstract][Full Text] [Related]
28. Altered DNA methylome profiles of blood leukocytes in Chinese patients with mild cognitive impairment and Alzheimer's disease.
Wu S; Yang F; Chao S; Wang B; Wang W; Li H; Yu L; He L; Li X; Sun L; Qin S
Front Genet; 2023; 14():1175864. PubMed ID: 37388929
[No Abstract] [Full Text] [Related]
29. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
30. Everyday Function in Alzheimer's and Parkinson's Patients with Mild Cognitive Impairment.
Becker S; Boettinger O; Sulzer P; Hobert MA; Brockmann K; Maetzler W; Berg D; Liepelt-Scarfone I;
J Alzheimers Dis; 2021; 79(1):197-209. PubMed ID: 33216023
[TBL] [Abstract][Full Text] [Related]
31. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.
Leifert WR; Nguyen T; Rembach A; Martins R; Rainey-Smith S; Masters CL; Ames D; Rowe CC; Macaulay SL; François M; Fenech MF;
J Alzheimers Dis; 2015; 48(2):443-52. PubMed ID: 26402008
[TBL] [Abstract][Full Text] [Related]
32. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
33. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
[TBL] [Abstract][Full Text] [Related]
34. Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment.
Guo M; Peng J; Huang X; Xiao L; Huang F; Zuo Z
J Alzheimers Dis; 2021; 80(1):299-310. PubMed ID: 33523001
[TBL] [Abstract][Full Text] [Related]
35. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
[TBL] [Abstract][Full Text] [Related]
36. Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer's Disease Neuroimaging Initiative database.
Abe K; Chiba Y; Hattori S; Yoshimi A; Asami T; Katsuse O; Suda A; Hishimoto A;
J Neurol Sci; 2020 Sep; 416():116989. PubMed ID: 32603972
[TBL] [Abstract][Full Text] [Related]
37. [Regression analysis of cerebral blood perfusion and cognitive function in patients with mild cognitive impairment and Alzheimer's disease].
Xu Y; Chen LL; Su Y; Sun SN; Zhang HY
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):193-197. PubMed ID: 30669762
[No Abstract] [Full Text] [Related]
38. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
[TBL] [Abstract][Full Text] [Related]
39. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
[TBL] [Abstract][Full Text] [Related]
40. Decreased circulating branched-chain amino acids are associated with development of Alzheimer's disease in elderly individuals with mild cognitive impairment.
Ikeuchi T; Kanda M; Kitamura H; Morikawa F; Toru S; Nishimura C; Kasuga K; Tokutake T; Takahashi T; Kuroha Y; Miyazawa N; Tanaka S; Utsumi K; Ono K; Yano S; Hamano T; Naruse S; Yajima R; Kawashima N; Kaneko C; Tachibana H; Yano Y; Kato Y; Toue S; Jinzu H; Kitamura A; Yokoyama Y; Kaneko E; Yamakado M; Nagao K
Front Nutr; 2022; 9():1040476. PubMed ID: 36590218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
